Chemically synthesized peptides come with free termini unless you ask otherwise: a positively charged amino group at the N-terminus and a negatively charged carboxyl group at the C-terminus. A protein does not present its internal sequences that way. N-terminal acetylation and C-terminal amidation remove those two artificial charges, and that one change affects stability, solubility and biological relevance together.
| N-terminal acetylation | C-terminal amidation | |
|---|---|---|
| Chemical change | Free α-amino group becomes an acetamide | Free α-carboxyl group becomes a primary amide |
| Charge effect | Removes the terminal positive charge | Removes the terminal negative charge |
| Protease effect | Slows digestion by aminopeptidases | Slows digestion by carboxypeptidases |
| Ordering code | {Ac} | {NH2} |
If your peptide comes from the middle of a protein, the residues on either side of it continue in the parent. A free charged terminus is an artefact of having cut the sequence out, and it sits exactly where the chain used to carry on. Capping both ends is the closest a linear peptide gets to presenting that region the way the protein does, which is why terminally modified peptides are the usual choice for functional studies, enzyme assays and anything where biological activity is the readout.
The effect is not merely theoretical. End-capped blocker peptides are routine in ion-channel work: an amidated analogue of the sea anemone peptide ShK is a potent and selective blocker of the Kv1.3 channel,1 and the acetylated, amidated peptide acetyl-KIFMK-amide was used to probe the inner cavity of cardiac sodium channels.2 In both cases the capped form is the one that works as a tool.
Removing two charges makes the molecule less polar. For a peptide that was already marginal — long, hydrophobic, or rich in beta-sheet-forming residues — capping can be the difference between dissolving and not. This is the single most common surprise with terminal modification, and it is worth planning for rather than discovering on the day the vial arrives.
Both must be requested before synthesis. Amidation requires starting from an amide resin, and acetylation is carried out on the resin before cleavage. In practice neither is added to a finished peptide: C-terminal amidation is normally designed in by starting on an amide resin, and acetylation is done on resin before cleavage. Post-synthetic routes to both do exist, but on a cleaved peptide they are hard to control — acetylation competes with lysine and other nucleophilic side chains, and amidating a free C-terminal acid selectively is harder still — so for practical purposes a change of terminal chemistry means remaking the peptide. If you are undecided, say so when ordering and we will discuss it before the synthesis starts.
| Situation | Recommendation |
|---|---|
| Peptide taken from inside a protein sequence, used for function or activity | Cap both ends. This is the standard choice. |
| The peptide really is the protein's own N- or C-terminus | Leave that end free. The charge is genuine, not an artefact. |
| Already poorly soluble, hydrophobic or aggregation-prone | Expect solubility to drop further. Consider capping one end only, or adding a solubilising tag. |
| Quantitative assay across several peptides | Keep the terminal state identical across the whole set, or the comparison is confounded. |
| ELISA and binding assays | Capping removes the influence of terminal charge on binding, which usually makes the readout cleaner. |
| Exopeptidase-containing media, serum or cell culture | Cap both ends. This is where the stability benefit is largest. |
Acetylation and amidation are the two we supply at no additional cost, but they sit in a wider family of terminal chemistry: formylation, succinylation, benzyloxycarbonyl and Boc protection, fatty-acid caps from butyric through palmitic and stearic acid, and C-terminal groups such as aldehyde, alcohol, AMC, pNA and chloromethylketone used in protease substrates. The full list with ordering codes is on the peptide modifications page.
Please email your project details to sales@lifetein.com or use our online quotation form. If you are not sure whether to cap, send the sequence and the assay and we will tell you what we would do.
Sequences supplied by customers are treated as confidential and are never disclosed or reused.
All LifeTein peptides are supplied for laboratory research use only. They are not for human or veterinary use, and not for diagnostic or therapeutic use.